Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: Evolution from the prethrombolysis to the percutaneous coronary intervention era

Kidney International

Volumn 84, Issue 2, 2013, Pages 353-358

  Nauta, Sjoerd T ^a   Van Domburg, Ron T ^a   Nuis, Rutger Jan ^a   Akkerhuis, Martijn ^a   Deckers, Jaap W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular; Cardiovascular disease; Epidemiology and outcomes

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITAL DISCHARGE; HUMAN; KAPLAN MEIER METHOD; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TREND STUDY;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881166989     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.71     Document Type: Article

References (27)

1. Johnston N, Dargie H, Jardine A. Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease: ischaemic heart disease. Heart 2008; 94: 1080-1088. (Pubitemid 352039898)
2. Medi C, Montalescot G, Budaj A et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv 2009; 2: 26-33.
3. Szummer K, Lundman P, Jacobson SH et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med 2010; 268: 40-49.
4. Wong JA, Goodman SG, Yan RT et al. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J 2009; 30: 549-557.
5. Szummer K, Lundman P, Jacobson SH et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 2009; 120: 851-858.
6. Fox CS, Muntner P, Chen AY et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 2010; 121: 357-365.
7. Hanna EB, Chen AY, Roe MT et al. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2011; 4: 1002-1008.
8. Nauta ST, Deckers JW, Akkerhuis M et al. Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008. PLoS One 2011; 6: e26917.
9. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensinconverting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42: 201-208. (Pubitemid 36851405)
10. Szummer K, Lundman P, Jacobson SH et al. Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney Int 2011; 79: 997-1004.
11. Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J 2012; 163: 399-406.
12. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295. (Pubitemid 39258422)
13. Charytan D, Mauri L, Agarwal A et al. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J 2006; 152: 558-564. (Pubitemid 44233426)
14. Coca SG, Krumholz HM, Garg AX et al. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006; 296: 1377-1384. (Pubitemid 44427424)
15. Latif F, Kleiman NS, Cohen DJ et al. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv 2009; 2: 37-45.
16. Herzog CA, Littrell K, Arko C et al. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 2007; 116: 1465-1472. (Pubitemid 47480637)
17. Januzzi JL, Cannon CP, DiBattiste PM et al. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol 2002; 90: 1246-1249. (Pubitemid 35350859)
18. Johnston N, Jernberg T, Lagerqvist B et al. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. Am Heart J 2006; 152: 1052-1058. (Pubitemid 44856711)
19. Charytan DM, Wallentin L, Lagerqvist B et al. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin J Am Soc Nephrol 2009; 4: 1032-1043.
20. McCullough PA, Sandberg KR, Borzak S et al. Benefits of aspirin and betablockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002; 144: 226-232. (Pubitemid 34879643)
21. Wright RS, Reeder GS, Herzog CA et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002; 137: 563-570.
22. van Domburg RT, Hoeks SE, Welten GM et al. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol 2008; 19: 158-163.
23. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
24. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
25. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-1953.
26. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254. (Pubitemid 46768608)
27. Nauta ST, Deckers JW, Akkerhuis KM et al. Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008. Diabetes Care 2012; 35: 2043-2047.